Biovet S.A. has conducted an in vitro trial that evaluate the molecular mechanisms of liver conditioner pronutrients.
Fungi and mycotoxins represent and important challenge in the way to achieve the performance objectives in farms, due to the negative effects they have on animals. To prevent mycotoxin consequences, it is essential to apply methods with a double focus: against mycotoxins and against the fungi that produce them.
Alquerfeed Antitox, mycotoxin binder of Biovet S.A., patented worldwide in 1988, has been proved effective throughout its more than 30 years on the market in all species and productive aptitudes. Several experimental and field trials confirm that it is a product useful for poultry, including broilers and laying hens, and even in less common species such as turkeys; as well as in pig farming, where it is used both in breeders and fattening pigs.
La presentación de la línea de multifuncionales Alquermix y el uso de Alquerfeed Antitox para la captación de aflatoxina B1 en cabras fueron las dos conferencias centrales de la tercera sesión del Simposium Internacional de Biovet, celebrado el 27 y 28 de mayo en la Cámara de Comercio de Tarragona, España.
Emily Branstad, presented a scientific poster on “Supplementation with Alquerfeed Antitox for the reduction of aflatoxin M1 in milk and biomarkers of liver function in dairy cows”, at the annual meeting of the American Dairy Science Association (ADSA).
The aim of this trial, conducted at Iowa State University (EE.UU), was to evaluate the reduction in aflatoxin absorption upon feeding with Alquerfeed Antitox, to prevent absorption by binding AF in the digestive tract. Absorption is estimated from AFM1 concentration in milk.